glp 1 lilly direct lowers self-pay prices of single-dose Zepbound vials Lilly is selling $12.9 billion

January 15, 2026: Strive Specialties Accuses Trulicitys Maker of Blocking Patients from Low-Cost, Customized GLP-1s Strive Specialties is a compounding drug company that makes low-cost, customized versions of medications, and it helped formulate some GLP-1s during past shortages

Future research should address long-term RCTs, head-to-head comparisons (e.g., vs

Attach a new needle if required by the pen

The Non-Negotiable Element: Purity in Research Whether you're studying a single peptide or a complex stack, there is one factor that can make or break your research before you even begin: the quality of your compounds

SSRP Institute: FDA Announces Change in Status of 12 Peptides CNBC: RFK Jr

Your immune system was designed for a simpler world